Pharmacy Benefit Manager Transparency Challenges

This document is a report that discusses the increasing scrutiny of pharmacy benefit managers (PBMs) due to their opaque practices and rising pharmacy costs. It outlines the challenges employers face regarding transparency in pricing, rebates, and formulary decisions, particularly concerning the major PBMs: CVS Caremark, Express Scripts, and OptumRx. The report highlights a significant shift in employer behavior, with a noted decline in the use of traditional PBMs and a rise in alternative pharmacy models that offer simplified pricing and greater transparency. It also addresses fiduciary risks and litigation exposure related to PBM management, citing a lawsuit against Johnson & Johnson as an example. Additionally, the document details the misaligned incentives in drug selection that can lead to higher costs for employers and plan participants. The report concludes by emphasizing the need for employers to adopt stronger governance and scrutiny over pharmacy benefits management as they navigate these challenges.